TREA

79313377 - OSTEOEDGE

Follow

Information

  • Trademark
  • 79313377
  • Serial Number
    79313377
  • Registration Number
    6776869
  • Filing Date
    February 24, 2021
    4 years ago
  • Registration Date
    July 05, 2022
    3 years ago
  • Transaction Date
    October 18, 2022
    3 years ago
  • Status Date
    July 05, 2022
    3 years ago
  • Published for Opposition Date
    April 19, 2022
    3 years ago
  • Location Date
    July 05, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BELL, MARLENE D
  • Attorney Docket Number
    WRA001 T328
    Attorney Name
    Matthew J. Stark
    Law Office Assigned Location Code
    M90
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
OSTEOEDGE
Case File Statements
  • GS0051: Stem cells for medical purposes; collagen for medical use; biodegradable implants being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implant materials being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; implantable materials being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; implants being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implants comprised of living tissues; medical therapeutic agents for tissue regeneration; medical therapeutic biological products, namely, biological cell cultures for medical purposes; medical preparations, namely, medical preparations for tissue regeneration; guided tissue regeneration materials, namely, materials for the regeneration of bone and soft tissue, namely, living tissue and nerve tissue; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in regeneration of damaged bone and soft tissue, namely, living tissue and nerve tissue; tissues for medical use being living cells; collagen based scaffolding for biomechanical support and stabilization, namely, implantable scaffolds comprising biological materials; cellular therapeutic tendon and cartilage regeneration products, namely, living cells or implantable scaffolds comprising biological materials
  • GS0441: Advisory services relating to medical services namely providing advice in the field of bone and soft tissue regeneration; medical services; medical advisory services; medical care services for the regeneration of bone and soft tissue; medical health assessment services; medical treatment services for the regeneration of bone and soft tissue; provision of medical information; provision of medical services; therapy services for the regeneration of bone and soft tissue; physical therapy; medical services, including those relating to biomechanical and cellular therapeutic medical techniques
  • GS0101: Medical implants, namely, implants made from artificial biomaterials, namely, synthetic collagen, for use in the regeneration of bone and soft tissue, and nerve tissue; orthopaedic implants, namely, implants made from artificial biomaterials for use in the regeneration of bone and soft tissue, and nerve tissue; surgical implants comprised of artificial materials; dental implants made of artificial materials; biodegradable bone fixation implants made of artificial materials; surgical implants comprised of artificial materials for use in guided tissue regeneration; surgical implants comprised of artificial materials for replacing human tissue; surgical prostheses, namely, implantable scaffolds comprising artificial materials for the regeneration of bone and soft tissue and nerve tissue; artificial skin for surgical purposes; surgical prosthesis implants made of artificial materials for use in human medicine; orthopaedic materials, namely, orthopaedic materials made from artificial biomaterials for use in the regeneration of bone and soft tissue, and nerve tissue; artificial orthopaedic implants; artificial materials for use in guided tissue regeneration, namely, implantable scaffolds comprising artificial biomaterials for the regeneration of bone and soft tissue, and nerve tissue; artificial replacement materials for human tissue, namely, synthetic collagen based scaffolding materials; surgical implants comprised of artificial materials for replacing animal and human tissue
Case File Event Statements
  • 10/18/2022 - 3 years ago
    28 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 10/18/2022 - 3 years ago
    27 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 10/5/2022 - 3 years ago
    26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 7/5/2022 - 3 years ago
    25 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 7/5/2022 - 3 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/3/2022 - 3 years ago
    23 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 4/19/2022 - 3 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/19/2022 - 3 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/13/2022 - 3 years ago
    20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/13/2022 - 3 years ago
    19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 3/30/2022 - 3 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/12/2022 - 3 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/11/2022 - 3 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/11/2022 - 3 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/11/2022 - 3 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/11/2022 - 3 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/18/2022 - 4 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/18/2022 - 4 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/18/2022 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/5/2021 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/12/2021 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/12/2021 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/26/2021 - 4 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/25/2021 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/19/2021 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/26/2021 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 6/22/2021 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 6/17/2021 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR